Travel Vaccines and Advice


We have a stock of common travel vaccines to most destinations.  If any unusual vaccination is required, we will be able to order the vaccine promptly.   On occasion, patients will need to purchase their vaccines from a pharmacist after their doctor provides a prescription.

Bayside Medical Group is accredited as a Yellow Fever vaccination provider.

We have access to current travel vaccination databases.

As travel vaccination can be complex, we recommend that you see a doctor in an appointment to discuss your itinerary and determine your vaccine requirements.  Travel immunisation can take up to six weeks to complete so consult your doctor as early as possible.

Further information may be found at Centre for Disease Control - Traveller's Health


travel overseas

RSS Disease Outbreak Alerts

  • Ebola virus disease – Democratic Republic of the Congo 15 November 2018
    New measures to overcome obstacles in responding to the Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo are having a positive impact. The Ministry of Health (MoH), WHO and partners continue to be confident that, despite challenges, the outbreak can be contained.
  • Ebola virus disease – Democratic Republic of the Congo 8 November 2018
    As the Ebola virus disease (EVD) outbreak enters the fourth month since declaration, and case numbers surpass 300, substantial progress has been achieved in all aspects of the response.
  • Middle East respiratory syndrome coronavirus (MERS-CoV) – Saudi Arabia 1 November 2018
    From 17 September through 15 October 2018, the International Health Regulations (IHR 2005) National Focal Point of Saudi Arabia reported eight additional cases of MERS-CoV infection, including three deaths. Of the eight cases reported, three were hospital contacts from one hospital in Dammam and two were household contacts in Riyadh. Details of these cases can […]
  • Ebola virus disease – Democratic Republic of the Congo 1 November 2018
    The increase over the past four weeks in confirmed case incidence (Figure 1), most notably in the city of Beni and communities around Butembo, is concerning.
  • Circulating vaccine-derived poliovirus type 2 – Niger 30 October 2018
    From July through September 2018, six cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) were reported from Niger, genetically linked to a cVDPV2 case in Jigawa and Katsina States, Nigeria. The virus was isolated from children with acute flaccid paralysis (AFP) from Zinder region, located in the south of Niger and on the border with […]